Oracle (NYSE:ORCL – Get Free Report) posted its quarterly earnings data on Monday. The enterprise software provider reported $1.39 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.06, Briefing.com reports. The firm had revenue of $13.31 billion for the quarter, compared to analysts’ expectations of $13.23 billion. Oracle had a net margin of 19.76% and a return on equity of 223.01%. The business’s quarterly revenue was up 6.9% on a year-over-year basis. During the same quarter last year, the company posted $0.95 EPS. Oracle updated its Q2 guidance to $1.45-1.49 EPS.
Oracle Stock Up 11.4 %
ORCL stock opened at $155.82 on Wednesday. The company has a market capitalization of $429.42 billion, a price-to-earnings ratio of 42.00, a price-to-earnings-growth ratio of 2.56 and a beta of 1.01. The company has a debt-to-equity ratio of 8.25, a quick ratio of 0.72 and a current ratio of 0.71. The business’s 50 day moving average price is $138.90 and its two-hundred day moving average price is $129.13. Oracle has a fifty-two week low of $99.26 and a fifty-two week high of $160.52.
Oracle Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 24th. Shareholders of record on Thursday, October 10th will be given a dividend of $0.40 per share. The ex-dividend date is Thursday, October 10th. This represents a $1.60 annualized dividend and a yield of 1.03%. Oracle’s payout ratio is 43.13%.
Insider Activity
Institutional Investors Weigh In On Oracle
A number of institutional investors have recently made changes to their positions in ORCL. Westend Capital Management LLC purchased a new stake in Oracle during the 1st quarter valued at $25,000. Fairway Wealth LLC purchased a new stake in Oracle during the 2nd quarter valued at $27,000. Tidemark LLC bought a new position in shares of Oracle during the 4th quarter valued at $29,000. Nordwand Advisors LLC purchased a new position in shares of Oracle in the 4th quarter worth $30,000. Finally, Frank Rimerman Advisors LLC bought a new stake in shares of Oracle in the fourth quarter worth $30,000. Hedge funds and other institutional investors own 42.44% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities analysts have recently commented on the company. Guggenheim reiterated a “buy” rating and set a $175.00 price objective on shares of Oracle in a research report on Tuesday, June 25th. StockNews.com upgraded shares of Oracle from a “hold” rating to a “buy” rating in a research report on Tuesday. BMO Capital Markets boosted their price objective on shares of Oracle from $160.00 to $173.00 and gave the stock a “market perform” rating in a report on Tuesday. Citigroup reduced their target price on shares of Oracle from $133.00 to $128.00 and set a “neutral” rating on the stock in a report on Monday, June 10th. Finally, Jefferies Financial Group boosted their price target on shares of Oracle from $150.00 to $170.00 and gave the stock a “buy” rating in a research note on Tuesday. Twelve equities research analysts have rated the stock with a hold rating and nineteen have given a buy rating to the stock. According to MarketBeat, Oracle currently has an average rating of “Moderate Buy” and an average target price of $157.52.
Check Out Our Latest Stock Report on Oracle
About Oracle
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Read More
- Five stocks we like better than Oracle
- How to Read Stock Charts for Beginners
- Don’t Miss Smartsheet’s Surge: Strong Growth and Buybacks Ahead
- 3 Healthcare Dividend Stocks to Buy
- Matador Resources Insiders Keep Buying Its Stock, Should You?
- Profitably Trade Stocks at 52-Week Highs
- Oracle Can Turn the Magnificent 7 Into 8: Here’s Why
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.